azacitidine and Purpura, Thrombocytopenic, Idiopathic

azacitidine has been researched along with Purpura, Thrombocytopenic, Idiopathic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Demir, AM; Demirci, U; Umit, EG1
Gao, Y; Gong, M; Kong, X; Ma, Y; Zhang, C1
Egle, A; Melchardt, T; Weiss, L1
Feng, Q; Hou, M; Hou, Y; Li, G; Li, L; Liu, X; Min, Y; Ni, H; Peng, J; Qiu, J; Shao, L; Wang, Y; Xu, S; Yang, L; Zhang, X; Zhou, H1

Other Studies

4 other study(ies) available for azacitidine and Purpura, Thrombocytopenic, Idiopathic

ArticleYear
A comment on "a prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia" by Zhou et al.
    American journal of hematology, 2020, Volume: 95, Issue:4

    Topics: Adult; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; Humans; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic

2020
Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article.
    Medicine, 2017, Volume: 96, Issue:43

    Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Benzoates; Decitabine; Dioxygenases; DNA-Binding Proteins; Drug Monitoring; Female; Hematologic Agents; Humans; Hydrazines; Leukemia, Myelomonocytic, Chronic; Middle Aged; Mutation; Nuclear Proteins; Platelet Count; Proto-Oncogene Proteins; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Ribonucleoproteins; Serine-Arginine Splicing Factors; Thrombocytopenia; Thrombopoietin; Treatment Outcome

2017
[Autoimmune hemolysis accompanied by thrombopenia: consumption or myelodysplasia?].
    Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:41

    Topics: Aged; Anemia, Hemolytic, Autoimmune; Antimetabolites, Antineoplastic; Azacitidine; Biopsy, Needle; Bone Marrow; Diagnosis, Differential; Disease Progression; Follow-Up Studies; Humans; Leukopenia; Male; Myelodysplastic Syndromes; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia

2013
Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia.
    Thrombosis and haemostasis, 2015, Volume: 113, Issue:5

    Topics: Adolescent; Adult; Aged; Azacitidine; Base Sequence; Blood Platelets; Case-Control Studies; Cell Differentiation; CpG Islands; Decitabine; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Flow Cytometry; Humans; Male; Megakaryocytes; Middle Aged; Molecular Sequence Data; Promoter Regions, Genetic; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia; TNF-Related Apoptosis-Inducing Ligand; Young Adult

2015